布地奈德联合特布他林雾化吸入辅助对小儿支气管哮喘的治疗作用探讨

Curative Effect Exploration of Budesonide Combined with Terbutaline Nebulized Inhalation As Adjuvant Therapy for Pediatric Bronchial Asthma

目的分析布地奈德、特布他林对小儿支气管哮喘的应用效果。方法选取2022年6月—2023年6月本院收治的84例小儿支气管哮喘患者开展研究,并按照随机分组法分为对照组和观察组,每组42例。其中,对照组行常规药物治疗,观察组选取布地奈德、特布他林,开展雾化吸入,比较两组患者临床疗效。结果两组生活质量、肺功能和症状体征均有差异(P<0.05),且观察组优于对照组。结论联合应用布地奈德与特布他林,并采用雾化吸入的给药方式,可有效提升小儿支气管哮喘的治疗效果,具备较高的推广价值。

Objective To analyze application effect of budesonide and terbutaline on pediatric infantile bronchial asthma.Methods The paper chose 84 children with infantile bronchial asthma in our hospital from June 2022 to June 2023 for study,and randomly divided them into control group of 42 cases treated with routine drug treatment,and observation group of 42 cases with budesonide and terbutaline through nebulization inhalation.Clinical effect was was compared.Results There was difference in life quality,lung function,and symptoms and signs between two groups(P<0.05).Conclusion Combination therapy,administered through nebulized inhalation,can enhance effect of infantile bronchial asthma,which has promotional value.